pubmed-article:3497885 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C0022499 | lld:lifeskim |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C0041044 | lld:lifeskim |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C0005508 | lld:lifeskim |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C1382107 | lld:lifeskim |
pubmed-article:3497885 | lifeskim:mentions | umls-concept:C0070203 | lld:lifeskim |
pubmed-article:3497885 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:3497885 | pubmed:dateCreated | 1987-10-19 | lld:pubmed |
pubmed-article:3497885 | pubmed:abstractText | Bioavailability of co-trimoxazole suspension was determined with and without concurrent administration of pectin and kaolin in 8 volunteers. Twenty ml suspension of co-trimoxazole containing 160 mg trimethoprim (TMP) and 800 mg sulphamethoxazole (SMX) and co-trimoxazole suspension along with 20 ml of pectin-kaolin suspension were administered in a random order with 7 days interval. Plasma estimation of trimethoprim and sulphonamide was carried out at serial intervals. Area under curve (AUC) and Cmax of TMP were significantly higher when co-trimoxazole suspension alone was used. No statistically significant changes were observed in case of sulphamethoxazole. Clinical study is necessary to verify whether concurrent administration of co-trimoxazole and pectin-kaolin leads to loss of antibacterial efficacy. | lld:pubmed |
pubmed-article:3497885 | pubmed:language | eng | lld:pubmed |
pubmed-article:3497885 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3497885 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3497885 | pubmed:month | Jun | lld:pubmed |
pubmed-article:3497885 | pubmed:issn | 0174-4879 | lld:pubmed |
pubmed-article:3497885 | pubmed:author | pubmed-author:GuptaK CKC | lld:pubmed |
pubmed-article:3497885 | pubmed:author | pubmed-author:GuptaCC | lld:pubmed |
pubmed-article:3497885 | pubmed:author | pubmed-author:DesaiN KNK | lld:pubmed |
pubmed-article:3497885 | pubmed:author | pubmed-author:SatoskarR SRS | lld:pubmed |
pubmed-article:3497885 | pubmed:author | pubmed-author:GoswamiS NSN | lld:pubmed |
pubmed-article:3497885 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3497885 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:3497885 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3497885 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3497885 | pubmed:pagination | 320-1 | lld:pubmed |
pubmed-article:3497885 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:meshHeading | pubmed-meshheading:3497885-... | lld:pubmed |
pubmed-article:3497885 | pubmed:year | 1987 | lld:pubmed |
pubmed-article:3497885 | pubmed:articleTitle | Effect of pectin and kaolin on bioavailability of co-trimoxazole suspension. | lld:pubmed |
pubmed-article:3497885 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3497885 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:3497885 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |